Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

NVP-LDE225  -  LDE 225

 

 

CAS 956697-53-3

C26H26F3N3O3  MW 485.50

Purity: 99%

 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1619       Prime Source

 

Qty1: 5 mg (research sample) / 130  $169

Promotion: 2 x 5 mg @ 190  $247

Qty2: 25 mg (research sample) / 450  $585

Promotion: 2 x 25 mg @ 650  $845

Qty3: on request contract research synthesis

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for our product range and services.

 

Biological Activity:

 

Potent, selective and orally bioavailable Smoothened (SMO) antagonist (IC50: 50 nM); it inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

 

References:

 

S Pan et al. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. ACS Med. Chem. Lett., 2010, 1 (3), pp 130–134. [online]

 

 

 

Chemical Name: N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4′-(trifluoromethoxy)biphenyl-3-carboxamide

 

NVP-LDE225 | SMO antagonist | Axon Medchem | Axon 1619 | LDE 225

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2011

 

Axon Ligands in the field:

 

GDC 0449 | SMO antagonist

NVP-LDE225 | SMO antagonist

 

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection